BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma
Active, not recruiting · NCT06414434 · Registry updated 2026-07-01Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BTX-A51 in Patients With Liposarcoma or CIC-rearranged Sarcoma | CIC-rearranged sarcoma, Neoplasms by Histologic Type, Neoplasms, Adipose Tissue, Neoplasms, Connective and Soft Tissue, liposarcoma, myxoid liposarcoma, neoplasm, sarcoma | Active, not recruiting | Phase 1 | 2026-07-01 | NCT06414434 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Edgewood Oncology Inc. | 3 |
| Michael Wagner, MD | 1 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Brigham and Women's Hospital | Boston | United States | 2 |
| Dana-Farber Cancer Institute | Boston | United States | 626 |